Database

Startups

Main Industry
Biotechnology
Main Product/Service
Maternal and Child Health Testing: Provides prenatal and postnatal chromosomal microarray screening, such as CytoOneArray, which can screen for more than 400 genetic disorders in a single test, including chromosomal abnormalities and developmental delays.
Precision Oncology: Develops breakthrough ctDNA methylation technology for early liver cancer screening, while also providing pharmacogenomic testing services for cancers such as breast cancer, colorectal cancer, and lung cancer.
Gynecologic Cancer Screening: Offers services such as the AmpliGene Test, enabling simultaneous screening for endometrial cancer and cervical cancer.
Research and Contract Manufacturing: Possesses high-density gene chip R&D and manufacturing capabilities, and provides customized gene chip design and processing services on an ODM/OEM basis.
Founded Year
2025
Unified Business No.
60763646
Status
Active
Total Paid-in Capital
170,000,000 (NT$)
Location of Company
Taiwan , Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
PHALANX BIOTECH specializes in developing genetic testing platforms, utilizing technologies like microarray chips, next-generation sequencing, and big data analysis.



more ↓

Similar Companies

CrackerBio, Inc.

1. NextAmp™ Analysis System
2. PanelChip®
3. DigiChip™ Digital PCR
4. ThyroSCAN
5. FusionQuest

LIFEOS GENOMICS CORPORATION

1. LifeOS Developed Assay Panels
2. Assay Co-Development
3. QLoci™ NIPT Assay Panel
4. Maximize your utility on the QLoci™ system.

TGIA, Inc.

TGIA offers high-throughput next-generation and third-generation sequencing services in Taiwan, utilising industry-grade systems such as Illumina NovaSeq X Plus, NovaSeq 6000 and PacBio Sequel IIe.
Their service portfolio spans whole genome sequencing a
:::
回頁面最頂端